Zobrazeno 1 - 10
of 142
pro vyhledávání: '"Shintaro Saito"'
Autor:
Hiroshi Mori, Hiroshi Wakabayashi, Shintaro Saito, Kenichi Nakajima, Kotaro Yoshida, Tomo Hiromasa, Seigo Kinuya
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract This study aimed to compare tumor lesion detectability and diagnostic accuracy of whole-body magnetic resonance imaging (WB-MRI) and radioiodine-labeled meta-iodo-benzylguanidine (mIBG) imaging techniques in patients with metastatic pheochro
Externí odkaz:
https://doaj.org/article/8e206736e24f4c729807436ea7041ef2
Autor:
Hiroshi Mori, Hiroshi Wakabayashi, Shintaro Saito, Kenichi Nakajima, Kotaro Yoshida, Tomo Hiromasa, Seigo Kinuya
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/cd9fbe83ae7a4c8da1fc5309ca1161d5
Publikováno v:
Journal of Cutaneous Immunology and Allergy, Vol 6, Iss 3, Pp 105-107 (2023)
Abstract Rosai–Dorfman disease (RDD) is a rare non‐Langerhans cell histiocytosis that was first described as sinus histiocytosis with massive lymphadenopathy by Rosai and Dorfman in 1969. While classical/nodal RDD is typical, extranodal involveme
Externí odkaz:
https://doaj.org/article/dd84a0a722f94778a59a1fd52080ef86
Autor:
Tatsuhiko Mori, Kenjiro Namikawa, Naoya Yamazaki, Yukiko Kiniwa, Osamu Yamasaki, Shusuke Yoshikawa, Takashi Inozume, Hiroshi Kato, Yasuo Nakai, Satoshi Fukushima, Tatsuya Takenouchi, Takeo Maekawa, Shigeto Matsushita, Atsushi Otsuka, Motoo Nomura, Natsuki Baba, Taiki Isei, Shintaro Saito, Noriki Fujimoto, Ryo Tanaka, Takahide Kaneko, Yutaka Kuwatsuka, Taisuke Matsuya, Kotaro Nagase, Masazumi Onishi, Takehiro Onuma, Yasuhiro Nakamura
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundAnti-programmed cell death protein 1 (PD-1) monotherapy is one of the standard systemic therapies for advanced melanoma; however, the efficacy of salvage systemic therapies after PD-1 monotherapy failure (PD-1 MF), particularly in acral mel
Externí odkaz:
https://doaj.org/article/d92b81c82c6941559fafef15d965897b
Publikováno v:
EJNMMI Research, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Background Since three-dimensional segmentation of cardiac region in 123I-metaiodobenzylguanidine (MIBG) study has not been established, this study aimed to achieve organ segmentation using a convolutional neural network (CNN) with 123I-MIBG
Externí odkaz:
https://doaj.org/article/60d89d746ae64a1d8d1e8c04f9993f21
Autor:
Shintaro Saito, Masahito Yasuda, Takeshi Araki, Azusa Ida, Yuko Kuriyama, Akihito Uehara, Chikako Kishi, Yukie Endo, Hiroomi Ogawa, Sei‐ichiro Motegi
Publikováno v:
Journal of Cutaneous Immunology and Allergy, Vol 6, Iss 1, Pp 24-25 (2023)
Externí odkaz:
https://doaj.org/article/4b61dbadd60d4bd6bd7551df2d07bd91
Autor:
Masahito Yasuda, Akihito Uehara, Shintaro Saito, Yuko Kuriyama, Kazuya Yamada, Aina Oka, Marie Miyagawa, Osamu Ishikawa, Sei‐Ichiro Motegi
Publikováno v:
Journal of Cutaneous Immunology and Allergy, Vol 6, Iss 1, Pp 30-31 (2023)
Externí odkaz:
https://doaj.org/article/5cf54e38c625499d90a1982ec2136735
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
Abstract is missing (Short communication)
Externí odkaz:
https://doaj.org/article/d49357dd80064178860664f05e070344
Autor:
Hiroshi Wakabayashi, Daiki Kayano, Anri Inaki, Raita Araki, Rie Kuroda, Norihito Akatani, Takafumi Yamase, Satoru Watanabe, Tomo Hiromasa, Yuji Kunita, Hiroshi Mori, Shintaro Saito, Yasuhiro Ikawa, Toshihiro Fujiki, Seigo Kinuya
Publikováno v:
Diagnostics, Vol 10, Iss 9, p 663 (2020)
123I-meta-iodobenzylguanidine (123I-mIBG) scintigraphy is used for evaluating disease extent in children with neuroblastoma. 131I-mIBG therapy has been used for evaluation in children with high-risk neuroblastoma, and post-therapy 131I-mIBG scintigra
Externí odkaz:
https://doaj.org/article/66f78a23b1f946638aa7f886539e7062
Autor:
Yasuhiro Nakamura, Kenjiro Namikawa, Yukiko Kiniwa, Hiroshi Kato, Osamu Yamasaki, Shusuke Yoshikawa, Takeo Maekawa, Shigeto Matsushita, Tatsuya Takenouchi, Takashi Inozume, Yasuo Nakai, Satoshi Fukushima, Shintaro Saito, Atsushi Otsuka, Noriki Fujimoto, Taiki Isei, Natsuki Baba, Taisuke Matsuya, Ryo Tanaka, Takahide Kaneko, Masazumi Onishi, Yutaka Kuwatsuka, Kotaro Nagase, Takehiro Onuma, Motoo Nomura, Yoshiyasu Umeda, Naoya Yamazaki
Publikováno v:
European Journal of Cancer. 176:78-87
Although anti-PD-1 antibody monotherapy (PD-1) is commonly used to treat advanced acral melanoma (AM), its efficacy is limited. Further, data on the efficacy of PD-1 plus anti-CTLA-4 antibody (PD-1+CTLA-4) for the treatment of AM are limited. Therefo